These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7555602)

  • 1. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus.
    Steindel BS; Roe TR; Costin G; Carlson M; Kaufman FR
    Diabetes Res Clin Pract; 1995 Mar; 27(3):199-204. PubMed ID: 7555602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA
    Evans-Cheung TC; Campbell F; Yong J; Parslow RC; Feltbower RG
    Diabet Med; 2019 Jan; 36(1):88-95. PubMed ID: 30059173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: A 2-year Swedish national survey of children and adolescents with type 1 diabetes.
    Wersäll JH; Adolfsson P; Forsander G; Hanas R
    Pediatr Diabetes; 2022 Nov; 23(7):1038-1044. PubMed ID: 35678764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
    Mack-Fogg JE; Orlowski CC; Jospe N
    Pediatr Diabetes; 2005 Mar; 6(1):17-21. PubMed ID: 15787897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.
    Weinzimer SA; Ahern JH; Doyle EA; Vincent MR; Dziura J; Steffen AT; Tamborlane WV
    Pediatrics; 2004 Dec; 114(6):1601-5. PubMed ID: 15574621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
    Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
    Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.
    Scrimgeour L; Cobry E; McFann K; Burdick P; Weimer C; Slover R; Chase HP
    Diabetes Technol Ther; 2007 Oct; 9(5):421-8. PubMed ID: 17931050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes.
    Babar GS; Ali O; Parton EA; Hoffmann RG; Alemzadeh R
    Diabetes Technol Ther; 2009 Mar; 11(3):131-7. PubMed ID: 19216689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
    Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    J Pediatr Endocrinol Metab; 2002 May; 15(5):607-12. PubMed ID: 12014519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
    Rodrigues IA; Reid HA; Ismail K; Amiel SA
    Diabet Med; 2005 Jul; 22(7):842-9. PubMed ID: 15975097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.